Seoul CRO

Seoul CRO is a South Korean contract research organization (CRO) that provides a full range of clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2009 as a joint venture involving Seoul National University, the company was later acquired by Daewoong Pharmaceutical in 2015. It specializes in Phase I through IV clinical trials, bioequivalence studies, and post-marketing surveillance (PMS). The company's service portfolio includes regulatory affairs, clinical operation, data management, biostatistics, and medical writing. Seoul CRO is recognized for its expertise in navigating the South Korean regulatory landscape and its strong ties to major academic medical centers.